[Comment] Can allogeneic stem cells improve outcomes after stroke?Stroke is the second leading cause of death1 and the third leading cause of disability2 worldwide. Acute reperfusion therapies can improve outcomes but are only accessed by about one in 20 patients with ischaemic stroke in the USA. The need exists for additional therapies that are accessible and effective for most patients.3 One strategy in this regard is to develop new therapies that have a longer time window than the 3–6 h window of reperfusion therapies.
You are not allowed to add comments!
No comments found!